4

OWNERSHIP DOCUMENT

Company: Olema Pharmaceuticals, Inc.
Filed: December 4, 2024
Period of Report: December 4, 2024
Accession Number: 0000921895-24-002886

View Document ↗ View on SEC.gov ↗